Creative Planning Oncocyte Corp Transaction History

Creative Planning

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	BUY	$0.2 - $0.35 $2,427 - $4,247	12,136 New	12,136 $2,000
Q2 2022 Aug 15, 2022	BUY	$0.86 - $1.53 $2,838 - $5,049	3,300 Added 21.56%	18,609 $17,000
Q4 2021 Feb 11, 2022	BUY	$2.04 - $3.59 $31,230 - $54,959	15,309 New	15,309 $33,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $260M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.